﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vioxx news stories on Newser</title><description>Read more Vioxx stories on Newser</description><link>http://www.newser.com/taggrid/2136/vioxx.html</link><image><url>http://img1-cdn.newser.com/images/newser-black250x40.gif</url><title>Vioxx news stories on Newser</title><link>http://www.newser.com/</link></image><copyright>2012 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Thu, 24 May 2012 15:55:42 CDT</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/133904/merck-will-pay-950-million-to-settle-justice-department-allegations-on-marketing-of-vioxx.html</guid><title>Merck Pays $950M to Settle Vioxx Charges</title><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=853255&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20111122154957' border='0' /&gt;Drug maker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx. The Justice Department said Merck will pay $321.6 million in criminal fines and $628.4 million as a civil settlement agreement. The company also will plead guilty to a misdemeanor charge that...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=853255&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20111122154957" type="image/jpg" medium="image"><media:description type="plain">In this 2004 photo, Vioxx is arranged on a counting tray.</media:description></media:content><link>http://www.newser.com/story/133904/merck-will-pay-950-million-to-settle-justice-department-allegations-on-marketing-of-vioxx.html</link><pubDate>Tue, 22 Nov 2011 15:49:38 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/43712/drug-companies-hide-data-from-docs.html</guid><title>Drug Companies Hide Data From Docs</title><dc:creator>Katherine Thompson</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=156817&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401000407' border='0' /&gt;Pharmaceutical companies aren't as upfront with doctors as they are with the government about their new products, a study finds. Though drug companies must provide the FDA with all of the data from clinical trials, related papers published in medical journals were found to omit info from 20% of the...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=156817&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401000407" type="image/jpg" medium="image"><media:description type="plain">Vioxx, an anti-inflammatory drug from Merck, doubled heart-attack risk, killing an estimated 27,000 people. The company's studies had glossed over the elevated risk.</media:description></media:content><link>http://www.newser.com/story/43712/drug-companies-hide-data-from-docs.html</link><pubDate>Wed, 26 Nov 2008 10:22:30 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/27488/court-tosses-32m-verdict-against-vioxx.html</guid><title>Court Tosses $32M Verdict Against Vioxx</title><dc:creator>Kevin Spak</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=104158&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401013122' border='0' /&gt;A Texas appellate court threw out a $32 million verdict against Merck today, citing a lack of evidence that Vioxx contributed to a man’s fatal heart attack. Lionel Garza was taking the painkiller when he died in 2001 at age 71, but was also a smoker with high blood pressure...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=104158&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401013122" type="image/jpg" medium="image"><media:description type="plain">Vioxx is arranged on a counting tray, laying on top of the bottle, at The Pennington Apothecary in a Pennington, N.J. file photo from Sept. 30, 2004. </media:description></media:content><link>http://www.newser.com/story/27488/court-tosses-32m-verdict-against-vioxx.html</link><pubDate>Wed, 14 May 2008 13:29:37 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/24606/merck-used-ghostwriters-to-draft-rosy-vioxx-studies.html</guid><title>Merck Used Ghostwriters to Draft Rosy Vioxx Studies</title><dc:creator>John Johnson</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=94723&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401014728' border='0' /&gt;Merck used its own ghostwriters to draft articles minimizing risks of its drug Vioxx, then found medical researchers to lend their names to the research, the Wall Street Journal reports. Merck, which pulled the painkiller from shelves four years ago over heart-attack risks, rejects the claims as "misleading." They appear...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=94723&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401014728" type="image/jpg" medium="image"><media:description type="plain">Vioxx is arranged on a counting tray in this 2004 file photo. </media:description></media:content><link>http://www.newser.com/story/24606/merck-used-ghostwriters-to-draft-rosy-vioxx-studies.html</link><pubDate>Tue, 15 Apr 2008 19:51:25 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/18458/merck-will-pay-650m-to-end-discount-probes.html</guid><title>Merck Will Pay $650M to End Discount Probes</title><dc:creator>Matt Cantor</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=71878&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401022151' border='0' /&gt;Drug company Merck will dish out $650 million to resolve lawsuits and probes into marketing schemes, the Wall Street Journal reports. Central to the investigations is the company’s “nominal pricing,” which slashed some drug prices by 90% for hospitals but hid the discounts from Medicaid, even though federal law demands...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=71878&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401022151" type="image/jpg" medium="image"><media:description type="plain">Vioxx is arranged on a counting tray, laying on top of the botttle, at The Pennington Apothecary in a Pennington,  N.J. file photo from Sept. 30, 2004. Merck and Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for four drugs, including Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday.  (AP Photo/Daniel Hulshizer, File)</media:description></media:content><link>http://www.newser.com/story/18458/merck-will-pay-650m-to-end-discount-probes.html</link><pubDate>Thu, 07 Feb 2008 15:59:45 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/13954/merck-recalls-1m-doses-of-vaccine-for-kids.html</guid><title>Merck Recalls 1M Doses of Vaccine for Kids</title><dc:creator>Wesley Oliver</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=54502&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401024612' border='0' /&gt;Merck is recalling almost a million doses of a childhood vaccine after it found evidence of contamination at one of its factories, the AP reports. The pharmaceutical giant says no children have been harmed after taking Hib, which prevents meningitis and pneumonia, but the company is recalling its 10 lots...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=54502&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401024612" type="image/jpg" medium="image"><media:description type="plain">Offices of the Merck &amp; Co. plant in Rahway, N.J., Merck's oldest plant, are seen in this July 19, 2002 file photo. (AP Photo/Mike Dere, file)</media:description></media:content><link>http://www.newser.com/story/13954/merck-recalls-1m-doses-of-vaccine-for-kids.html</link><pubDate>Wed, 12 Dec 2007 19:14:29 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/11326/merck-to-settle-suits-for-485b.html</guid><title>Merck to Settle Suits for $4.85B</title><dc:creator>Colleen Barry</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=44279&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401030026' border='0' /&gt;Merck has agreed to shell out $4.85 billion to settle 27,000 Vioxx lawsuits brought by plaintiffs who argued that the pain medication damaged health and caused deaths. The agreement, one of the largest in history, must still be approved by 85% of the plaintiffs, but it's likely to...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=44279&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401030026" type="image/jpg" medium="image"><media:description type="plain">Vioxx is arranged on a counting tray, laying on top of the botttle, at The Pennington Apothecary in Pennington,  N.J., in this Sept. 30, 2004 file photo.  (AP Photo/Daniel Hulshizer, file)</media:description></media:content><link>http://www.newser.com/story/11326/merck-to-settle-suits-for-485b.html</link><pubDate>Fri, 09 Nov 2007 05:19:07 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html</guid><title>Drug Company Nemesis Strikes Again</title><dc:creator>Sam Gale Rosen</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=5064&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035008' border='0' /&gt;The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=5064&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035008" type="image/jpg" medium="image"><media:description type="plain">Steven Nissen, M.D. poses at the 56th Annual American College of Cardiology Conference Scientific session in New Orleans, Monday, March 26, 2007. (AP Photo/Judi Bottoni)</media:description></media:content><link>http://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html</link><pubDate>Tue, 22 May 2007 13:32:41 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/2066/fda-given-new-muscle-to-monitor-drugs.html</guid><title>FDA Given New Muscle To Monitor Drugs</title><dc:creator>Peter Fearon</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=4142&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035150' border='0' /&gt;The Food and Drug Administration would be given sweeping new powers to order drug recalls, regulate advertising and mandate changes in labels under a bill passed by the Senate yesterday. The bill signals a fundamental shift in the FDA's role, the New York Times reports, requiring the agency to track...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=4142&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035150" type="image/jpg" medium="image"><media:description type="plain"> </media:description></media:content><link>http://www.newser.com/story/2066/fda-given-new-muscle-to-monitor-drugs.html</link><pubDate>Thu, 10 May 2007 05:41:03 CDT</pubDate></item></channel></rss>
